Raoul Nelson
Pediatric Nephrology · Salt Lake City, UTNPI 1972682540
Payments from drug & device makers
$888,092in general payments, 2019–2025
Across 150 payments — averaging $5920.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$199K
- Amgen$129K
- Akebia Therapeutics Inc$116K
- Novartis$116K
- Hoffmann-la Roche Limited$106K
- AbbVie$94K
- plus $128K from 5 others
What the payments were for
- Travel & lodging$1,49969%
- Food & beverage$65930%
- Education$80%
General payments by program year
20
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $199,026 |
| Amgen | 18 | $129,142 |
| Akebia Therapeutics Inc | 28 | $115,787 |
| Novartis | 8 | $115,622 |
| Hoffmann-la Roche Limited | 34 | $106,340 |
| AbbVie | 25 | $94,068 |
| Bayer | 19 | $78,532 |
| Sanofi | 6 | $36,622 |
| AstraZeneca | 2 | $10,863 |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | 3 | $2,058 |
| Travere Therapeutics, Inc. | 3 | $34 |
How this compares
Too few pediatric nephrology providers in Utahto place this figure against a meaningful peer group, so we don't.
Other pediatric nephrology in Salt Lake City
- Joseph SherbotieSalt Lake City$143K
- David HooperSalt Lake City$61K
- Jessica StahlSalt Lake City$2K
- Meredith SeamonSalt Lake City$8
- Matthew GrinsellSalt Lake City$4
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.